Government and private health plans are taking a hard line in 2018 to ensure that pathology groups and clinical labs are complying with new laws and regulations, and managed care contract terms. The new year will bring significant changes to patient billing practices, out-of-network claims, lab audit initiatives, and lab sales protocols. These challenges all boil down to one thing: tougher actions by government and private payers which add up to negative financial consequences for the nation's pathology groups.
Featured XIFIN Speaker
Vice President, Commercialization Strategies, Consulting & Industry Affairs
Karen Lovitch, Leader, Health Law Practice at Mintz Levin
Richard Faherty, Consultant
This webinar will give you the right strategies to save your lab thousands in penalties, compliance costs, and other revenue hits, and set you on the right path to a profitable 2018!
Here is just some of what you'll learn during this in-depth 90-minute conference:
PAMA MARKET PRICE REPORTING - Get up-to-the-minute updates plus exclusive insights about what the processes your lab needs to put into place now and in 2018PRIOR AUTHORIZATIONS BY PAYERS – How are payers implementing their genetic test prior-authorization programs? How should your lab deal with these prior-authorization requirements?AUDIT ACTIVITY – Hear about new items now being focused on, the tactics being used, and how you can mitigate your audit riskBILLING COMPLIANCE – From medical necessity issues, to co-pay and deductibles, and beyond, here is everything you need to know
SALES AND MARKETING – Get the why's and how's of the latest compliance issues that you must address, sales activities that put you at risk, and how to avoid those pitfalls
...and much more!